Table 7. | Clinical data of the included studies |
| Study | Survival rate (%) |
Marginal bone loss (mm) |
Bleeding on probing |
Pocket probing depth (mm) |
Implant stability quotient | Complications | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SIG | LIG | SIG | LIG | SIG | LIG | SIG | LIG | SIG | LIG | SIG | LIG | |
| Maxilla | ||||||||||||
| Felice et al. [29] | 94.8 | 100 | 1.52 (SD 0.47) | 1.85 (SD 0.51) | NR | NR | NR | NR | NR | NR | 2 | 5 |
| Bechara et al. [31] | 100 | 95.6 | 0.201 (95% CI: 0.166; 0.236) | 0.273 (95% CI: 0.232; 0.313) | NR | NR | NR | NR |
68.2 to 72.4 (3 years) |
67.8 to 71.6 (3 years) |
0 | 19 |
| Nielsen et al. [32] | 100 | 100 | 0.28 (SD 0.17) | 0.26 (SD 0.14) | 24% | 22% | 2.4 (SD 0.5) | 2.5 (SD 0.6) | NR | NR | 2 | 17 |
| Guljé et al. [33] | 89.5 | 90.9 | 0.18 (SE 0.1) | 0.26 (SE 0.12) | 0.4 (SE 0.1) | 0.6 (SE 0.2) | 2.8 (SE 0.2) | 3.3 (SE 0.3) | NR | NR | 41.2% PIM |
30% PIM 10% Peri-implantitis |
| Thoma et al. [34] | 98.5 | 100 | 0.36 (SD 0.76) | 0.65 (SD 1.28) | 55.2% | 28.1% | 3.2 (SD 0.9 | 3.4 (SD 1.5) | NR | NR |
53.3% PIM 3.3% peri-implantitis |
45.5% PIM 16.3% peri-implantitis |
| Shah et al. [35]* | 84 | 96 | 0.6 (SD 0.16) | 0.86 (SD 0.2) | NR | NR | NR | NR |
67.9 (SD 8.3) to 70.17 (SD 7.4) (3 months) |
70.8 (SD 7.6) to 72.03 (SD 5.9) (3 months) |
NR | NR |
| Bolle et al. [36] | 91.8 | 82.9 | 0.63 (SD 0.15) | 0.72 (SD 0.25) | NR | NR | NR | NR | NR | NR | 4 | 12 |
| Mandible | ||||||||||||
| Bernardi et al. [28] | 94.1 | 84.5 | NR | NR | NR | NR | NR | NR | NR | NR | 8 | 22 |
| Felice et al. [29] | 95.1 | 93.6 | 1.34 (SD 0.35) | 2.11 (SD 0.59) | NR | NR | NR | NR | NR | NR | 3 | 14 |
| Felice et al. [30] | 81.4 | 80 | 1.49 (SD 0.4) | 2.34 (SD 0.75) | NR | NR | NR | NR | NR | NR | 6 | 25 |
| Bolle et al. [36] | 95.3 | 97.8 | 0.51 (SD 0.16) | 0.77 (SD 0.21) | NR | NR | NR | NR | NR | NR | 2 | 11 |
*This study did not separately assess the outcomes for the mandible and maxilla.
|
.png)
.png)
.png)
.png)
.png)
.png)